Breaking News

Financial Report: Patheon 3Q11

Excluding currency fluctuations, revenues were flat in the quarter.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 3Q11  3Q Revenues: $172.7 million (+6%) 3Q Loss: $0.7 million (loss of $3.0 million in 3Q10) YTD Revenues: $518.4 million (+5%) YTD Loss: $11.4 million (loss of $3.2 million YTD10) Comments: Excluding currency fluctuations, revenues were flat in the quarter. Revenues from commercial manufacturing operations in the quarter were $138.7 million (+7%). PDS revenues were flat at $34.0 million. Loss from continuing operations was $3.2 million compared to a loss of $1.0 million in 3Q10. Co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters